About Anton Mat

This author has not yet written his bio.
Meanwhile let's just say that we are proud Anton Mat contributed with 17 entries.

Entries by Anton Mat

ISA reports highlights of randomized Phase 2 cancer vaccine trial in head & neck cancer

ISA to Present at the 4th Annual Virtual H.C. Wainwright HBV Conference on October 25th

First Patient with Chronic Hepatitis B Dosed with ISA104 in First-in-Human Phase 1 Study

The combination of ISA101b and Libtayo® shows promising results in patients whose head and neck cancer progressed on anti-PD1 therapy

ISA to Present First Clinical Trial Data from the Phase II Study of ISA101b and Libtayo® (cemiplimab) Combination in Head and Neck Cancer at the ASCO Annual Meeting 2023

ISA to Present Pre-clinical Data on its Protective SLP Therapy Against SARS-CoV-2 at the CIMT Annual Meeting

ISA Pharmaceuticals to Attend and Present at Upcoming Scientific and Business Conferences

ISA Pharmaceuticals and Cancer Focus Fund Announce $5 Million Investment to Support First-in-Human Trial of ISA’s Novel Immunotherapy ISA103 in Uveal Melanoma

ISA Completes Enrolment in Randomized Double Blind Phase 2 Clinical Trial of ISA101b in HPV16 induced Oropharyngeal Cancer

First-in-Human Study: Amplivant® Adjuvant Boosts Immune Response of Synthetic Long Peptide Immunotherapy